Replies to post #107349 on PharmaCyte Biotech Inc (PMCB)

[esusun]

PMCB + Austrianova is a buyout target , with a cutting edge technology. This is Fact.

I dont care if we have 2bb shs outstanding when we complete a successful clinical trial for pancreatic cancer .

at min , a $1BB acquisition at that point , maybe later 2020, or maybe 2021 .

I can easily retire when / if PMCB hits $0.50

now is the time to be buying PMCB

Glad to see the weak hands fold .

[$Pistol Pete$]

Very well said my Friend and good morning